We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

News   Jul 15, 2020 | Original story from Keck Medicine of USC

 
Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

Keck Medicine of USC physicians are participating in a clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19. Credit: Ricardo Carrasco III

 
 
Advertisement
 

RELATED ARTICLES

100 Million-Year-Old Seabed Microbes Revived

News

Researchers reveal that given the right food in the right laboratory conditions, microbes collected from sediment as old as 100 million years can revive and multiply, even after laying dormant since large dinosaurs prowled the planet.

READ MORE

Four-Stranded DNA Plays a Role in Certain Types of Breast Cancer

News

Four stranded DNA structures called G-quadruplexes have been shown to play a role in certain types of breast cancer, providing a potential new therapeutic target.

READ MORE

How Bacteria Protect Themselves With Slime in Changing Temperatures

News

Researchers show that the bacterium Clostridium perfringens modulates biofilm structure, a protected mode of growth, at different temperatures by regulating the expression of the novel extracellular protein BsaA.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE